Stealthy Silverback recruits Seattle Genetics’ Eric Dobmeier as CEO, filling C-suite with oncology talent
A stealthy Silverback Therapeutics has been building up its C-suite with top talent from a pair of high profile biotechs in the Seattle area. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.